Lite Strategy, Inc. Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)
Lite Strategy, Inc. (LITS) reported Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) of $0 for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-19.
Discontinued › Income Statement › Other Income
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2024-09-19
- Lite Strategy, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2024-06-30 was $0.00.
- Lite Strategy, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2024-03-31 was $0.00.
- Lite Strategy, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Lite Strategy, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Lite Strategy, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Lite Strategy, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2023 was $1.60M, a 92.28% decline from fiscal 2022.
- Lite Strategy, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2022 was $20.75M, a 14.51% increase from fiscal 2021.
- Lite Strategy, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2021 was $18.12M.
| Period end | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 9 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $0.00 derived: sum of 2 quarters · filed 2024-09-19 | $0.00 derived: sum of 3 quarters · filed 2024-09-19 | $0.00 10-K · filed 2024-09-19 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 4 quarters · filed 2024-09-19 |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-13 | $0.00 10-Q · filed 2024-02-13 | $0.00 derived: sum of 3 quarters · filed 2024-09-19 | $0.00 derived: sum of 4 quarters · filed 2024-09-19 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2024-09-19 | $0.00 derived: sum of 3 quarters · filed 2024-09-19 | $486.00K derived: sum of 4 quarters · filed 2024-09-19 |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $0.00 derived: sum of 2 quarters · filed 2024-09-19 | $486.00K derived: sum of 3 quarters · filed 2024-09-19 | $1.60M 10-K · filed 2024-09-19 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $486.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.60M 10-Q · filed 2024-05-09 | $1.54M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $486.00K 10-Q · filed 2024-02-13 | $1.60M 10-Q · filed 2024-02-13 | $1.54M derived: sum of 3 quarters · filed 2024-02-13 | $14.31M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $1.12M 10-Q · filed 2023-11-09 | $1.05M derived: sum of 2 quarters · filed 2023-11-09 | $13.82M derived: sum of 3 quarters · filed 2023-11-09 | $19.28M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-26 | $12.71M derived: sum of 2 quarters · filed 2023-09-26 | $18.16M derived: sum of 3 quarters · filed 2023-09-26 | $20.75M 10-K · filed 2023-09-26 |
| 2022-03-31 | $12.77M 10-Q · filed 2023-05-11 | $18.23M derived: sum of 2 quarters · filed 2023-05-11 | $20.82M 10-Q · filed 2023-05-11 | $27.91M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $5.46M 10-Q · filed 2023-02-09 | $8.05M 10-Q · filed 2023-02-09 | $15.13M derived: sum of 3 quarters · filed 2023-02-09 | $5.86M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $2.59M 10-Q · filed 2022-11-14 | $9.67M derived: sum of 2 quarters · filed 2022-11-14 | $402.00K derived: sum of 3 quarters · filed 2022-11-14 | $7.49M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | -$2.19M derived: sum of 2 quarters · filed 2022-09-08 | $4.90M derived: sum of 3 quarters · filed 2022-09-08 | $18.12M 10-K · filed 2022-09-08 |
| 2021-03-31 | -$9.27M 10-Q · filed 2022-05-23 | -$2.19M derived: sum of 2 quarters · filed 2022-05-23 | $11.04M 10-Q · filed 2022-05-23 | -$20.40M derived: sum of 4 quarters · filed 2022-09-08 |
| 2020-12-31 | $7.08M 10-Q/A · filed 2022-05-23 | $20.31M 10-Q/A · filed 2022-05-23 | -$11.13M derived: sum of 3 quarters · filed 2022-09-08 | -$3.39M derived: sum of 4 quarters · filed 2022-09-08 |
| 2020-09-30 | $13.22M 10-Q/A · filed 2022-05-23 | -$18.21M derived: sum of 2 quarters · filed 2022-09-08 | -$10.48M derived: sum of 3 quarters · filed 2022-09-08 | -$18.91M derived: sum of 4 quarters · filed 2022-09-08 |
| 2020-06-30 | -$31.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | -$23.70M derived: sum of 2 quarters · filed 2022-09-08 | -$32.14M derived: sum of 3 quarters · filed 2022-09-08 | -$22.87M 10-K · filed 2022-09-08 |
| 2020-03-31 | $7.73M 10-Q · filed 2021-05-06 | -$707.00K derived: sum of 2 quarters · filed 2021-05-06 | $8.56M 10-Q · filed 2021-05-06 | $22.92M derived: sum of 4 quarters · filed 2022-05-23 |
| 2019-12-31 | -$8.44M 10-Q · filed 2021-02-04 | $830.00K 10-Q · filed 2021-02-04 | $15.19M derived: sum of 3 quarters · filed 2022-05-23 | $9.99M derived: sum of 4 quarters · filed 2022-05-23 |
| 2019-09-30 | $9.27M 10-Q · filed 2020-11-10 | $23.63M derived: sum of 2 quarters · filed 2022-05-23 | $18.43M derived: sum of 3 quarters · filed 2022-05-23 | $41.86M derived: sum of 4 quarters · filed 2022-05-23 |
| 2019-06-30 | $14.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-23 | $9.16M derived: sum of 2 quarters · filed 2022-05-23 | $32.59M derived: sum of 3 quarters · filed 2022-05-23 | $27.63M 10-K/A · filed 2022-05-23 |
| 2019-03-31 | -$5.20M 10-Q · filed 2020-05-07 | $18.24M derived: sum of 2 quarters · filed 2020-05-07 | $13.27M 10-Q · filed 2020-05-07 | $3.57M derived: sum of 4 quarters · filed 2020-09-09 |
| 2018-12-31 | $23.44M 10-Q · filed 2020-02-06 | $18.48M 10-Q · filed 2020-02-06 | $8.77M derived: sum of 3 quarters · filed 2020-09-09 | $8.77M derived: sum of 4 quarters · filed 2020-09-09 |
| 2018-09-30 | -$4.96M 10-Q · filed 2019-11-07 | -$14.67M derived: sum of 2 quarters · filed 2020-09-09 | -$14.67M derived: sum of 3 quarters · filed 2020-09-09 | -$14.67M derived: sum of 4 quarters · filed 2020-09-09 |
| 2018-06-30 | -$9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09 | -$9.71M derived: sum of 2 quarters · filed 2020-09-09 | -$9.71M derived: sum of 3 quarters · filed 2020-09-09 | -$9.71M 10-K · filed 2020-09-09 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-05-09 | $0.00 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $0.00 10-Q · filed 2019-02-07 | $0.00 10-Q · filed 2019-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |